baber/WOPTO huggingface dataset:
Patent NZ-262848-A (NZ)
Title: Fluid flow measurement in duct with acoustic non-fundamental modes controlled between transducers in modified duct cross-section
Inventor: BIGNELL NOEL
IPC: G01F1/66
Filed: 1994-03-07
Abstract: PCT No. PCT/AU94/00104 Sec. 371 Date Oct. 27, 1995 Sec. 102(e) Date Oct. 27, 1995 PCT Filed Mar. 7, 1994 PCT Pub. No. WO94/20821 PCT Pub. Date Sep. 15, 1997The present invention relates to a fluid flow arrangement where the effects of high order acoustic modes are suppressed in ultrasonic flow measurement. In one embodiment, ultrasonic transducers are arranged in a duct configured to carry a fluid. Ultrasonic signals between the transducers travel in a plurality of high order modes having velocities slower than a fundamental mode whose time of flight is desired to determine with accuracy. A measurement portion between the transducers is adapted to suppress the propagation of the non-fundamental modes.
Patent NZ-264675-A (NZ)
Title: Use of3-(4-azepino, -pyrrolidino and -piperidinoethoxybenzoyl)-2-(4-hydroxyphenyl)-7-hydroxybenzothiophene derivatives and the corresponding dihydronaphthalene derivatives in the preparation of medicaments for the inhibition of smooth muscle cell proliferation or of restinosis
Inventor: CULLINAN GEORGE JOSEPH
IPC: A61K31/55
Filed: 1994-10-13
Abstract: Methods of inhibiting smooth muscle cell proliferation and restinosis comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula <CHEM>  or <CHEM>     wherein R1 and R3 are independently hydrogen, -CH3, <CHEM>  or <CHEM>  wherein Ar is optionally substituted phenyl;     R2 is <CHEM>  and R4 is hydrogen or -OR1, and pharmaceutically acceptable salts and solvates thereof. Also provided is a method for inhibiting restinosis.
Patent NZ-298059-A (NZ)
Title: Receptor from rat forebrain tissue and benzopyran derivatives for use in diagnostic methods and therapeutic compositions
Inventor: HERDON HUGH JONATHAN
IPC: A61P25/28
Filed: 1995-12-11
Abstract: The present invention relates to a novel receptor in substantially pure form, to a soluble form of the receptor and it's use as a therapeutic agent, to a method of screening compounds useful in treating disorders by interacting with the receptor. A receptor in substantially pure form obtainable from rat forebrain tissue which is characterised in that: a)	trans-(+)-6-acetyl-4S-(4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-1benzopyran-3R-ol binds to it with a Kd of 40 nM for the rat forebrain tissue; b)	trans-(+)-6-acetyl-4S-(4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-1benzopyran-3R-ol binds to it with a Bmax of 220 pmol/g protein for rat forebrain tissue; c)	(3S,4S)-6-acetyl-3,4-dihydro-2,2-dimethyl-4-(3-iodophenylcarbonylamino)-2H-benzo[b]pyran-3-ol binds to it with a Kd of 2nM for the rat forebrain tissue; d)	(3S,4S)-6-acetyl-3,4-dihydro-2,2-dimethyl-4-(3-iodophenylcarbonylamino)-2H-benzo[b]pyran-3-ol binds to it with a Bmax of 220 pmol/g protein for rat forebrain tissue; and homologous receptors from other sources sharing at least 85 % homology with the rat forebrain tissue; wherein the receptors from rat forebrain tissue and the receptors from other sources have a molecular weight in the region of 130 Kd when analysed by SDS-gel electrophoresis.
Patent NZ-307044-A (NZ)
Title: Angiostatin fragments with antiangiogenic activity
Inventor: FOLKMAN M JUDAH
IPC: A61K35/76
Filed: 1996-04-26
Abstract: Pharmaceutical compositions are provided comprising angiostatin fragments which correspond to kringle region fragments of a plasminogen molecule.  The angiostatin fragments have antiangiogenic activity and provide a means for inhibiting angiogenesis of tumours and for treating angiogenic-mediated disease.
Patent NZ-310332-A (NZ)
Title: Self cleaning filter with back flushing
Inventor: CARACCIOLO LOUIS D
IPC: B01D33/11
Filed: 1996-06-07
Abstract: The present invention relates to a filter unit, and a filtering system using the filter unit, comprising a housing having a longitudinal axis and an inlet and outlet for fluid containing solid contaminants and a back-flush inlet and back-flush outlet for cleansing fluid. This housing contains a substantially cylindrical filter element which has a longitudinal axis coincident with the longitudinal axis of the housing. The filter element has disposed within it a conduit, adapted to be opened to atmospheric discharge, having a longitudinal axis coincident with the longitudinal axis of the filter element. The conduit also has disposed along its surface cleansing members, which extend from the conduit to the filter element and have apertures to allow the cleansing fluid to flow through the members and into the conduit. The filter unit rotates the conduit and/or the filter element about its longitudinal axis and detects when the degree of contamination of the filter unit in service reaches a level at which the flow of fluid containing solid contaminants through the filter unit drops below an effective level. The filter unit also comprises closes the inlet and outlet for fluid containing solid contaminants and opens the inlet and outlet for cleansing fluid to atmospheric discharge when the degree of contamination reaches that level.
Patent NZ-332694-A (NZ)
Title: Antimicrobial composition containing manuka oil (leptospermum scoparium) and Australian tea tree oil (melaleuca alternifolia)
Inventor: COURTNEY WILLIAM JOHN
IPC: A01N65/28
Filed: 1998-11-06
Abstract: A broad spectrum antimicrobial composition comprising the oils of leptospermum scoparium (LS) and melaleuca alternifolia (MA), exhibits increased antimicrobial activity than if the components are used in isolation.  In order to target gram negative microbes, the proportion of MA oil in the composition should be higher than that of LS.  The proportion of LS oil in the composition should be higher than that of MA, in order to target gram positive microbes The high potency fractions of LS have an RI of between 1482 and 1610, and include Flavesone, Isoleptospermone and Leptospermone.  The high potency fractions of MA oil include Terpinen-4-ol, and have an RI of between 1179 and 1610, and 920 and 1142.
Patent NZ-335516-A (NZ)
Title: Hair dye comprising p-phenyldiamine, p-aminophenol, 2-methyl-5-N-(b-hydroxyethyl)aminophenol, enzyme of 2-electron oxidoreductase and one donor for the said enzyme
Inventor: DE LABBEY ARNAUD
IPC: A61K8/99
Filed: 1998-09-28
Abstract: A ready-to-use composition for the oxidation dyeing of keratin fibers, in particular human keratin fibers such as hair.  The composition comprises 1)	para-phenylenediamine and/or at least one of the addition salts thereof with an acid, as a first oxidation base. 2)	at least one second oxidation base chosen from para-aminophenols. 3)	2-methyl-5-N-(b-hydroxyethyl)aminophenol and/or at least one of the addition salts thereof with an acid, as a coupler. 4)	At least one enzyme of 2-electron oxido-reductase type 5)	At least one donor for the above enzyme.
Patent NZ-506536-A (NZ)
Title: Roof construction includes valance strips for ring beam and ridge member
Inventor: RICKMAN PAUL DOUGLAS
IPC: E04D3/08
Filed: 1999-03-12
Abstract: A conservatory roof construction comprises a ring beam 10 adapted to be laid around the surfaces of the conservatory walls, a ridge member 12 and a plurality of glazing bars 13 extending between ridge member 12 and ring-beam 10.  The inwardly-directed faces of ring beam 10 and ridge member 12 are trimmed with elongate valance strips 26, 53.  Each strip 26, 53 are of substantially the same configuration.
Patent NZ-521068-A (NZ)
Title: 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
Inventor: FISCHER PETER MARTIN
IPC: C07D417/14
Filed: 2001-03-28
Abstract: Disclosed are 4-heteroaryl-pyrimidine compounds of formula I, wherein: X1 is CH and X2 is S, or one of X1 and X2 is S and the other is N, Z is NH, NHCO, NHSO2, NHCH2, CH2, CH2CH2 or CH=CH, R1, R2 and R3 are independently H, alkyl, aryl, aralkyl, heterocycle, halogeno, NO2, CN, OH, alkoxy, aryloxy, NH2, NH-R', N-(R')(R''), NH-COR', NH-aryl, N-(aryl)2, COOH, COO-R', COO-aryl, CONH2, CONH-R', CON-(R')(R''), CONH-aryl, CON-(aryl)2, SO3H, SO2NH2, CF3, CO-R' or CO-aryl, and are optionally substituted, R4, R5, R6, R7 and R8 are independently H, optionally substituted alkyl, halogeno, NO2, CN, OH, optionally substituted alkoxy, NH2, NH-R', alkyl-aryl, alkyl-heteroaryl, NH(C=NH)NH2, N(R')3+, N(R')(R''), COOH, COO-R', CONH2, CONH-R', CON-(R')(R''), SO3H, SO2NH2CF3 or (CH2)nO(CH2)mNR'R'', (CH2)nCO2(CH2)mOR''', and R', R'', R''' are independently alkyl. The compounds are used in the manufacture of medicaments for treating proliferative diseases.
Patent NZ-521390-A (NZ)
Title: Nucleoside analogs with carboxamidine-modified bicyclic base for use in modulating Type 1 and Type 2 Helper T-cells
Inventor: TAM ROBERT
IPC: A61P17/00
Filed: 2001-02-15
Abstract: Nucleoside analog compounds are disclosed. These compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Type 1 cytokine and Type 2 cytokine activity.
Patent NZ-526010-A (NZ)
Title: Method and device for desalting water
Inventor: WOBBEN ALOYS
IPC: B01D61/02
Filed: 2001-07-18
Abstract: The invention relates to a method and a device for desalting water with reverse osmosis, especially for desalting seawater. According to said method, the saltwater (10) is fed into a pressure compensation device (2) at a first pressure (p1) and is then led from said pressure compensation device (2) into a membrane module (3) at a second, higher pressure (p2). Desalted water (12) and concentrated saltwater (13) are guided out of the membrane module (3) and the concentrated saltwater (13) from the membrane module (3) is continuously fed into the pressure compensation device at approximately the second pressure (p2). Here, said concentrated saltwater is used to subject the saltwater (10) that is fed into the pressure compensation device (2) to approximately the second pressure (p2) and to feed the saltwater (11) into the membrane module (3). The introduction of the concentrated saltwater (13) into the pressure compensation device (2) and the guiding of the concentrated saltwater (14) out of the pressure compensation device (2) takes place by means of controlled main valves (V1, V3, V4, V6). Said main valves are subjected to a considerable mechanical load, especially during opening and closing. In order to reduce or avoid this, the invention provides that secondary valves (V2, V2', V5, V5') that are situated parallel to the main valves (V1, V3, V4, V6) are controlled in such a way that the load peaks are reduced for opening and/or closing the main valves (V1, V3, V4, V6).
Patent NZ-528058-A (NZ)
Title: A material for a dimensionally stable anode for the electrowinning of aluminium
Inventor: JULSRUD STEIN
IPC: C25C3/12
Filed: 2002-02-13
Abstract: A material suitable for use as the active anode surface in the electrolytic reduction of alumina to aluminium metal defined by the formula: A1+xB1+deltaCdO4 where A is a divalent cation or a mixture of cations with a relative preference for octahedral coordination, B is a trivalent cation or mixture of cations with a relative preference for tetrahedral coordination, C is a trivalent cations with a relative preference for octahedral coordination or a tetravalent cation with a relative preference for octahedral coordination, O is the element oxygen: When C is trivalent x=0, 0.8<delta<1, delta<0.2 and x+delta+d is essentially equal to 1. When C is tetravalent 0.4<x<0.6, 0.4<d<0.6, delta <0.2 and x+d+delta is essentially equal to 1.
Patent NZ-531093-A (NZ)
Title: Chemo-enzymatic synthesis of sialylated oligosaccharides
Inventor: DEFREES SHAWN
IPC: C12P19/44
Filed: 2002-08-01
Abstract: In vitro/cell-free process of preparing a sialylated oligosaccharides are described. The sialylated oligosaccharides include gangliosides. The oligosaccharides linked to various moieties including sphingoids and ceramides. Novel compounds that comprise sphingoid groups are disclosed. The compounds include sialylated oligosaccharides including gangliosides as well as various sphingoids and ceramides
Patent NZ-540257-A (NZ)
Title: Cognitive abilities improving agent obtained from Pinus bark
Inventor: FREVEL MATHIAS ALFONS EVERHARD
Filed: 2005-05-23
Abstract: Described is a method of improving, or preventing a decline in, human cognitive abilities where the human does not suffer from any kind of medical condition that could impair cognitive abilities, but where the decline in cognitive abilities may be age-associated, wherein the human consumes a composition containing an extract obtained from the bark of trees of the genus Pinus.
Patent NZ-540484-A (NZ)
Title: Stable, clear, aqueous ifosfamide compositions for parenteral administration and a process for their preparation
Inventor: DAFTARY GAUTAM VINOD
IPC: A61K9/00
Filed: 2003-12-02
Abstract: Disclosed herein is a stable, clear, aqueous ifosfamide compositions having reduced toxicity, for parenteral administration comprising ifosfamide up to 1100 mg/ml of the composition and 2-hydroxypropyl-beta-cyclodextrin.
Patent NZ-541228-A (NZ)
Title: Lining material for pipelines
Inventor: DAVELOOSE FRANK
IPC: F16L55/163
Filed: 2003-10-31
Abstract: A tubular lining material for reinforcing pipelines, utilizable in a pipe-lining method wherein the tubular lining material, having a binder disposed on the inner surface thereof, is inserted into a pipeline and is allowed to advance within the pipeline as the tubular lining material is turned inside out under fluid pressure whereby the tubular lining material is applied to the inner surface of the pipeline with the binder being interposed between the pipeline and the tubular lining material, said tubular lining material comprising an outer layer of an impervious material and provided on the inside thereof with an inner reinforcing tubular jacket wherein the inner reinforcing tubular jacket comprises at least two sheets of high tensile strength and/or high modulus fibers and wherein the sheets overlap at least two locations and wherein said overlap portions extend in the lengthwise direction of the inner tubular jacket.
Patent NZ-541453-A (NZ)
Title: Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof
Inventor: HILLEN HEINZ
IPC: C07K16/18
Filed: 2004-02-02
Abstract: Disclosed are neuromodulatory oligomers of the amyloid-beta (1-42) protein, a specific method of preparation by which the oligomers are obtained in a reproducible manner at high yield and the use of the oligomers as diagnostic and therapeutic agents for the generation of oligomer-specific antibodies and for finding substances that interact with the oligomers.
Patent NZ-542040-A (NZ)
Title: A process of preparing imatinib
Inventor: KANKAN RAJENDRA NARAYANRAO
IPC: C07D401/04
Filed: 2004-01-08
Abstract: Disclosed is a process of preparing imatinib, either as the free base or as an acid addition salt which process comprises reacting N-(2-methyl-5-aminophenyl)-4-(3-pyridyl)-2-pyrimidine amine of formula (II) with a 4-(4-methyl-piperazino methyl)benzoyl halide of formula (III) in the absence of a base and in the presence of an inert organic solvent, so as to yield a hydrohalide salt of imatinib of formula (I) where n represents 1, 2 or 3 and Hal represents bromo, chloro, fluoro or iodo, wither in anhydrous or hydrated form which can as desired optionally be further converted either to the free base or a further acid addition salt.
Patent NZ-542546-A (NZ)
Title: Suction wand holder
Inventor: CURRIE QUENTIN ISAAC
Filed: 2005-09-22
Abstract: A single use disposable tube shaped holder, of one-piece construction, for holding a suction wand or suction instrument. The holder includes hooks to clip to a side of an anaesthetic machine and may be formed by injection moulding or blow moulding. The holder may be made from a translucent polypropylene or similar plastic material.
Patent NZ-544539-A (NZ)
Title: Combinations comprising antimuscarinic agents and beta-adrenergic agonists
Inventor: GRAS ESCARDO JORDI
IPC: A61K31/137
Filed: 2005-05-31
Abstract: Disclosed is a combination which comprises (a) a beta-2-adrenergic agonist and (b) an antagonist of M3 muscarinic receptors which is 3(R)-(2-Hydroxy-2,2- dithien-2-ylacetoxy)-1 -(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane, in the form of a salt having an anion X, which is a pharmaceutically acceptable anion of a mono or polyvalent acid.
Patent NZ-544586-A (NZ)
Title: Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
Inventor: BERGAUER MARKUS
IPC: C07D409/12
Filed: 2004-07-15
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are useful in the treatment of CNS disorders such as depression or anxiety.
Patent NZ-546965-A (NZ)
Title: Fungicidal mixtures for the prevention of rice pathogens
Inventor: TORMO I BLASCO JORDI
IPC: A01N43/90
Filed: 2004-11-05
Abstract: The disclosure relates to fungicidal mixtures, for the prevention of rice pathogens, comprising the following active components, (a) the triazolopyrimidine derivative of formula (I); and (b) propiconazole of formula (II), in synergistically effective amounts. A method for the prevention of rice pathogens with mixtures of compound (I) with compound (II) and use of compound (I) with compound (II) for the production of such mixtures and means comprising said mixtures is disclosed.
Patent NZ-550441-A (NZ)
Title: Arylsulfonyl benzodioxanes useful for modulating the 5-HT6 receptor, the 5-HT2A receptor or both
Inventor: BERGER JACOB
IPC: C07D319/20
Filed: 2005-04-27
Abstract: Disclosed are arylsulphonyl benzodioxane and arylsulphonyl benzoxathiane derivatives of formula I or pharmaceutically acceptable salts thereof. Also disclosed is a pharmaceutical composition which comprises an effective amount of the above compound in admixture with a pharmaceutically acceptable carrier. The use of the above compounds for the preparation of a medicament for treating a central nervous system disease state (wherein the disease state is selected from psychoses, schizophrenia, manic depressions, neurological disorders, memory disorders, attention deficit disorder, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, food uptake disorders, and Huntington's disease) in a subject is further disclosed. Additionally, the use of an arylsulphonyl benzodioxane or arylsulphonyl benzoxathiane derivative of formula I or a pharmaceutically acceptable salt thereof for the preparation of a medicament for treating a disorder of the gastrointestinal tract in a subject is also disclosed.
Patent NZ-553080-A (NZ)
Title: A device for receiving implanted biological material
Inventor: RICORDI CAMILLO
IPC: A61F2/02
Filed: 2005-07-20
Abstract: A device, which can be implanted into a patient, and receives implantable biological material, is disclosed. The device has a porous outer wall, which defines an inner space for receiving the implanted biological material. The outer wall allows vasculature from the patient to pass through to the implanted tissue. The device includes a pump coupled to a fluid manifold assembly, for infusing immunosuppressive or growth factor media into the implanted tissue, instead of into the patient's body.
Patent NZ-565286-A (NZ)
Title: Ionic liquid reconstituted cellulose composites as solid support matrices
Inventor: ROGERS ROBIN D
IPC: C09D101/00
Filed: 2006-06-27
Abstract: Disclosed is a cellulose/active substance composite, comprising a regenerated cellulose matrix, a first active substance substantially homogeneously distributed within the matrix of regenerated cellulose, a linker, and a second active substance, wherein the linker is bonded to the first and second active substances. Also disclosed is a method for preparing a cellulose/active substance composite, comprising: a) providing a composition comprising a regenerated cellulose matrix and a first active substance, wherein the first active substance is substantially homogeneously distributed within the regenerated cellulose matrix; b) contacting the first active substance with a linker to bond the linker to the first active substance; and c) contacting a second active substance with the linker to bond the linker to the second active substance, thereby providing a cellulose/active substance composite.
Patent NZ-565296-A (NZ)
Title: Garment for storing and/or carrying items
Inventor: SWINDELLS DARREN
IPC: A41D1/00
Filed: 2006-07-19
Abstract: A garment 10 for storing and/or carrying one or more items, comprises a torso receiving portion 14 for wearing on at least part of a wearer's torso, and one or more receptacles 16, 18, 20, 22, 24 for receiving the item/s, with each receptacle 16, 18, 20, 22, 24 being at least partially comprised of a semi-rigid polymeric material. Each receptacle 16, 18, 20, 22, 24 is integrated with the torso receiving portion 14 by either integral forming or moulding in which at least part of the receptacles 16, 18, 20, 22, 24 are formed or moulded together with at least part of the torso receiving portion into one or more integral pieces.
Patent NZ-569104-A (NZ)
Title: Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
Inventor: SMITH-SWINTOSKY VIRGINIA L
IPC: A61K31/353
Filed: 2006-12-19
Abstract: Disclosed is the use of benzo-fused heterocycle sulfamide compounds of formula (I), wherein the substituents are as defined in the specification, for treating mania and bipolar disorder.
Patent NZ-570307-A (NZ)
Title: A game
Inventor: HASSALL FLORENCE JOAN
IPC: A63F3/04
Filed: 2008-08-06
Abstract: A game is provided, which includes: a) a display or surface depicting a map of part or all of the world, which is broken up into two or more distinct regions, each of which being provided with a home base for a player, b) travelling routes depicted on the display or surface connecting the two or more regions and/or home bases, c) a marker for each player which is able to travel along the travelling routes, d) a first random probability means for determining the allowable extent of movement of a player's marker along the travelling routes, e) a second random probability means for determining whether an action is to be undertaken by a player, and if so, the action being based on, or provided in relation to, a historical event, and f) a commodity associated with each of the regions. The arrangement and construction is such that each player is encouraged to maximise the amount and/or value of their total commodities (obtained from any region), according to the rules and variants of the game substantially as described herein, whereby the winner of the game is determined to be the player with the highest number and/or value of total commodities at the end of the game.
Patent NZ-578336-A (NZ)
Title: A balustrade system
Inventor: EVANS SCOTT
IPC: E04B2/82
Filed: 2009-07-13
Abstract: A balustrade system including a plurality of balustrade posts (1) comprising of an aluminium extruded or plastic moulded section post, the post having glazing slots (11), the post being connected to a base plate (3) that has stainless steel or aluminium folded cover plates (8).